Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin.

[1]  K. Moghissi,et al.  Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. , 1988, The New England journal of medicine.

[2]  K. Moghissi,et al.  Comparison of different treatment modalities of endometriosis in infertile women. , 1987, Fertility and sterility.

[3]  J. Devogelaer,et al.  LHRH ANALOGUES AND BONE LOSS , 1987, The Lancet.

[4]  H. Judd,et al.  Treatment of Endometriosis With a Long‐Acting Gonadotropin‐Releasing Hormone Agonist , 1987, Obstetrics and gynecology.

[5]  J. Evers.  The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. , 1987, Fertility and sterility.

[6]  W. Dmowski.  Visual assessment of peritoneal implants for staging endometriosis: do number and cumulative size of lesions reflect the severity of a systemic disease? , 1987, Fertility and sterility.

[7]  E. Thomas,et al.  Impact of gestrinone on the course of asymptomatic endometriosis. , 1987, British medical journal.

[8]  W. Willemsen,et al.  Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients. , 1986, European journal of obstetrics, gynecology, and reproductive biology.

[9]  S. Monroe,et al.  Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). , 1985, Fertility and sterility.

[10]  N. Faure,et al.  Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. , 1984, Fertility and sterility.

[11]  H. Fraser,et al.  Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. , 1983, British medical journal.

[12]  M. Seibel,et al.  The effectivenss of danazol on subsequent fertility in minimal endometriosis. , 1982, Fertility and sterility.

[13]  R. Barbieri,et al.  Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up , 1982 .

[14]  C. Martin,et al.  Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. , 1981, American journal of obstetrics and gynecology.

[15]  Schweppe Kw,et al.  Ultrastructural Changes in Endometriotic Implants During the Menstrual Cycle , 1981, Obstetrics and gynecology.

[16]  R. Rolland,et al.  Assessment of unconjugated oestradiol and progesterone serum levels throughout pregnancy in normal women and in women with hyperprolactinaemia, who conceived after bromocriptine treatment. , 1977, Acta endocrinologica.

[17]  Friedlander Rl.  The treatment of endometriosis with danazol. , 1973 .

[18]  R. Greenblatt,et al.  Clinical studies with an antigonadotropin-Danazol. , 1971, Fertility and sterility.

[19]  R. Kistner.  The use of newer progestins in the treatment of endometriosis. , 1958, American journal of obstetrics and gynecology.

[20]  Karnaky Kj.  The use of stilbestrol for endometriosis; preliminary report. , 1948 .

[21]  R. Dickey,et al.  Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone. , 1984, Fertility and sterility.